[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- [Mover Over Lithium - 220 Pounds of Graphite In Every EV Battery]( [See Why Investors Are So Excited About This New Mineral Claim Discovery]( --------------------------------------------------------------- January 05, 2023 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [The Coming Copper Bull Run]( prices have nearly doubled since last year -- driven by the explosive growth in electric vehicles and soaring demand for green-powered electricity. But copper demand far outpaces supply. Multinational investment banks are predicting a 50% to 100% rise in copper prices by 2025. And this "backdoor" play may be a move to consider. [Find out how you can slip into copper through the back door.]( --------------------------------------------------------------- [9 Meters Biopha, NMTR]( Recent Analyst Action: Naz Rahman, analyst at Maxim Group, reiterates coverage on [9 Meters Biopha (NMTR)](in the Healthcare sector with a Hold rating and a price target of n/a (1 month ago). - Recent Price: $$2.21 - Average Analyst Price Target: $54.50 (2366.06%) - Market Cap: $$25.39M [TipRanks.com]( also reports that [9 Meters Biopha](currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $54.50 . The target pricing ranges from a high forecast of $74.00 down to a low forecast of $35.00. [9 Meters Biopha (NMTR)](’s last closing price was $$2.21 which would put the average price target at $$54.50. Here are 3rd party ratings for [NMTR](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 27% (67 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [The Dividend Stock to Leave for Your Grandchildren]( you tired of your so-called "safe" income stocks slashing dividends while the share prices fall? There is a better way. I just revealed my safest most reliable and [most consistent dividend stock]( - and it pays a sky high yield with dividends paid EVERY month. This company has also increased its monthly dividend twice a year every year for the past 8 years. [Tap here to reveal the name of this stock for free.]( --------------------------------------------------------------- [Charah Solutions, CHRA]( Recent Analyst Action: Michael E., analyst at Stifel Nicolaus, reiterates coverage on [Charah Solutions (CHRA)](in the Services sector with a Buy rating and a price target of $170.00 (6 days ago). - Recent Price: $$7.96 - Average Analyst Price Target: $57.88 (627.14%) - Market Cap: $$27.21M [TipRanks.com]( also reports that [Charah Solutions](currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $57.88 . The target pricing ranges from a high forecast of $170.00 down to a low forecast of $1.65. [Charah Solutions (CHRA)](’s last closing price was $$7.96 which would put the average price target at $$57.88. Here are 3rd party ratings for [CHRA](: - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Sell, Bottom 17% (207 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- [Checkpoint Ther, CKPT]( Recent Analyst Action: Jennifer Kim, analyst at Cantor Fitzgerald, reiterates coverage on [Checkpoint Ther (CKPT)](in the Healthcare sector with a Buy rating and a price target of $15.00 (1 day ago). - Recent Price: $$6.71 - Average Analyst Price Target: $35.33 (426.53%) - Market Cap: $$103.91M [TipRanks.com]( also reports that [Checkpoint Ther](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $35.33 . The target pricing ranges from a high forecast of $76.00 down to a low forecast of $15.00. [Checkpoint Ther (CKPT)](’s last closing price was $$6.71 which would put the average price target at $$35.33. Here are 3rd party ratings for [CKPT](: - TipRanks.com: Strong Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- [Zai Lab, ZLAB]( Recent Analyst Action: Michael Yee, analyst at Jefferies, reiterates coverage on [Zai Lab (ZLAB)](in the Healthcare sector with a Buy rating and a price target of $65.00 (2 weeks ago). - Recent Price: $$48.09 - Average Analyst Price Target: $85.50 (77.79%) - Market Cap: $$3.27B [TipRanks.com]( also reports that [Zai Lab](currently has 6 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $85.50 . The target pricing ranges from a high forecast of $127.00 down to a low forecast of $64.00. [Zai Lab (ZLAB)](’s last closing price was $$48.09 which would put the average price target at $$85.50. Here are 3rd party ratings for [ZLAB](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: hold - Zacks.com: Hold, Top 27% (67 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- [Generation Bio, GBIO]( Recent Analyst Action: Whitney Ijem, analyst at Canaccord Genuity, reiterates coverage on [Generation Bio (GBIO)](in the Healthcare sector with a Buy rating and a price target of $9.00 (1 month ago). - Recent Price: $$5.59 - Average Analyst Price Target: $14.33 (156.35%) - Market Cap: $$301.87M [TipRanks.com]( also reports that [Generation Bio](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $14.33 . The target pricing ranges from a high forecast of $23.00 down to a low forecast of $9.00. [Generation Bio (GBIO)](’s last closing price was $$5.59 which would put the average price target at $$14.33. Here are 3rd party ratings for [GBIO](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Buy, Top 18% (44 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [The Humble Mineral at the Heart of the EV Revolution (Not Lithium)]( may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite - more than lithium, copper or aluminum! [Get the Full Story On This New American Graphite Opportunity.]( --------------------------------------------------------------- [Check-Cap, CHEK]( Recent Analyst Action: Yi Chen, analyst at H.C. Wainwright, reiterates coverage on [Check-Cap (CHEK)](in the Healthcare sector with a Buy rating and a price target of $15.00 (1 month ago). - Recent Price: $$2.65 - Average Analyst Price Target: $15.00 (466.04%) - Market Cap: $$15.83M [TipRanks.com]( also reports that [Check-Cap](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $15.00 . The target pricing ranges from a high forecast of $15.00 down to a low forecast of $15.00. [Check-Cap (CHEK)](’s last closing price was $$2.65 which would put the average price target at $$15.00. Here are 3rd party ratings for [CHEK](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 40% (101 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- [Personalis, PSNL]( Recent Analyst Action: Michael Matson, analyst at Needham, reiterates coverage on [Personalis (PSNL)](in the Healthcare sector with a Hold rating and a price target of n/a (11 hours ago). - Recent Price: $$2.33 - Average Analyst Price Target: $8.60 (269.10%) - Market Cap: $$100.22M [TipRanks.com]( also reports that [Personalis](currently has 7 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $8.60 . The target pricing ranges from a high forecast of $13.00 down to a low forecast of $5.00. [Personalis (PSNL)](’s last closing price was $$2.33 which would put the average price target at $$8.60. Here are 3rd party ratings for [PSNL](: - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Hold, Top 18% (44 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [The 800-lb Chinese Gorilla]( consumes 54% of the world's copper. Yet China mines only 8% of its copper needs, while plundering Africa, Latin America and South America for copper. The U.S. is left scrambling for new copper sources. But there's a North American copper sweet spot overlooked by China – for now. [Find Out Where This Copper Hotspot Is and How You Can Benefit]( --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software